Harvard Bioscience, Inc. (HBIO) shares outstanding

Shares outstanding · fiscal 2025
4.44M

Harvard Bioscience, Inc. (HBIO) had 4.44M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.0% higher than the 4.35M of fiscal 2024. Figures as of 18 Nov 2026, 12:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
4.44M
Change on fiscal 2024
+2.0%
Growth, 5 years
+2.8% a year
Growth, 10 years
+2.8% a year
Highest on record
4.44Mfiscal 2025
Lowest on record
2.98Mfiscal 2012
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Harvard Bioscience, Inc. shares outstanding, in more detail

The market data feed counts 4.57M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.8% a year; over ten years the rate was 2.8% a year. Across the 17 fiscal years on record (2009–2025), the highest was 4.44M in fiscal 2025 and the lowest 2.98M in fiscal 2012.

History · 17 fiscal years

Shares outstanding by fiscal year

Harvard Bioscience, Inc. shares outstanding, year by year

Harvard Bioscience, Inc. (HBIO) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
20254.44M 2.0% up
20244.35M 2.6% up
20234.24M 2.4% up
20224.14M 2.7% up
20214.03M 4.4% up
20203.86M 2.2% up
20193.78M 3.7% up
20183.65M 4.9% up
20173.48M 1.6% up
20163.42M 1.8% up
20153.36M 1.1% up
20143.32M 4.1% up
20133.19M 7.1% up
20122.98M 0.1% down
20112.98M 23.1% down
20103.88M 1.8% down
20093.95M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on HBIO

Harvard Bioscience, Inc., figure by figure

Harvard Bioscience, Inc. (HBIO) overview: price, valuation and scorecard

Harvard Bioscience, Inc. shares outstanding: questions and answers

How many shares does Harvard Bioscience, Inc. have?

Harvard Bioscience, Inc. (HBIO) had 4.44M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.0% higher than the 4.35M of fiscal 2024. The market data feed counts 4.57M shares outstanding today.

What is the growth rate of Harvard Bioscience, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.8% a year; over ten years the rate was 2.8% a year.

What are the highest and lowest diluted share count figures on record for Harvard Bioscience, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was 4.44M in fiscal 2025 and the lowest 2.98M in fiscal 2012.

How is Harvard Bioscience, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Harvard Bioscience, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Harvard Bioscience, Inc. (HBIO) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/HBIO/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.